Ryan,
It's getting old isn't it. If I hadn't researched this company as close as I have, I would have probably already pulled out. Watching ones investment erode by several thousand dollars over the last few days hasn't been fun. I have decided to go in and buy more tomorrow. At this price the downside has to be very limited.
I haven't gotten a response from my E-mail yet. I assume that is because Monday was a holiday. All of my previous E-mails were answered on the following business day, so I expect an answer by tomorrow night.
I believe that the earnings are suppose to be out on the 20th.
Zacks and First Call have revised earning estimates out today for ACMI. The best I can tell no broker has changed their estimate but a new broker's estimate has been added which changed the mean estimate.
Zacks: EPS Estimates for quarter ending 9/97 is -0.06, year ending 12/97 is -0.30, and year ending 12/98 +0.23. Next five year growth rate is still 50% per year.
First Call: EPS Estimates for quarter ending 9/97 is -0.07, year ending 12/97 is -0.37, and year ending 12/98 is +0.23.
ACMI retained its Strong Buy consensus from the brokers following the company in both Zacks and First Call. It also retained its number one ranking out of 61 in the MED/DENTAL-SUPP group.
All I can say about the revised earning estimates is that it reduces the chances of a negative surprise.
For comparsion ACMI, NPTH, and CYTC closed $0.28 (9.6%), $0.87 (4.5%), and $2.25 (7.6%) respectively off their previously high close of the last week. There appears to be weakness across the entire group this last week. One of these years I am going to learn to take my ball home and not play in October. In my opinion most of the damage is already done.
Cisco |
